Beam Therapeutics, Inc. (BEAM)
25.13
-0.57
(-2.22%)
USD |
NASDAQ |
Oct 12, 16:00
25.18
+0.05
(+0.20%)
Pre-Market: 08:19
Beam Therapeutics Total Return Level : 25.13 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 25.13 |
| October 09, 2026 | 25.70 |
| October 08, 2026 | 24.60 |
| October 07, 2026 | 24.77 |
| October 06, 2026 | 25.23 |
| October 05, 2026 | 25.67 |
| October 02, 2026 | 24.50 |
| October 01, 2026 | 24.39 |
| September 30, 2026 | 24.45 |
| September 29, 2026 | 24.52 |
| September 28, 2026 | 24.23 |
| September 25, 2026 | 24.27 |
| September 24, 2026 | 24.66 |
| September 23, 2026 | 24.37 |
| September 22, 2026 | 25.93 |
| September 21, 2026 | 25.26 |
| September 18, 2026 | 24.95 |
| September 17, 2026 | 24.67 |
| September 16, 2026 | 23.10 |
| September 15, 2026 | 23.22 |
| September 14, 2026 | 24.12 |
| September 11, 2026 | 23.99 |
| September 10, 2026 | 24.37 |
| September 09, 2026 | 25.18 |
| September 08, 2026 | 26.83 |
| Date | Value |
|---|---|
| September 04, 2026 | 29.66 |
| September 03, 2026 | 29.46 |
| September 02, 2026 | 29.29 |
| September 01, 2026 | 29.02 |
| August 31, 2026 | 29.43 |
| August 28, 2026 | 29.32 |
| August 27, 2026 | 30.48 |
| August 26, 2026 | 30.19 |
| August 25, 2026 | 31.03 |
| August 24, 2026 | 28.33 |
| August 21, 2026 | 29.76 |
| August 20, 2026 | 28.39 |
| August 19, 2026 | 29.07 |
| August 18, 2026 | 26.57 |
| August 17, 2026 | 27.10 |
| August 14, 2026 | 26.75 |
| August 13, 2026 | 26.51 |
| August 12, 2026 | 26.71 |
| August 11, 2026 | 26.85 |
| August 10, 2026 | 27.28 |
| August 07, 2026 | 27.48 |
| August 06, 2026 | 27.25 |
| August 05, 2026 | 27.07 |
| August 04, 2026 | 28.35 |
| August 03, 2026 | 25.91 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Prime Medicine, Inc. | 3.61 |
| Intellia Therapeutics, Inc. | 12.58 |
| Twist Bioscience Corp. | 151.86 |
| Q32 Bio, Inc. | 8.74 |
| Sarepta Therapeutics, Inc. | 17.44 |